Show items per page
Elements: 120
Page 3 on 3
 TitleAuthors / EditorsDate
add to browser selection
Secondary Prevention of Venous Thromboembolism: One Regimen May Not Fit All Bounameaux, Henri; Blondon, Marc 2015
add to browser selection
Stenting carotidien: place de l'evidence-based medicine! Bounameaux, Henri; De Moerloose, Philippe; Mazzolai, L. 2010
add to browser selection
Swiss results from a global observational study of venous thromboembolism risk and prophylaxis use in the acute care hospital setting: analysis from the ENDORSE study Chopard, Pierre; Spirk, David; Beer, Hans-Jurg; Peter, Jurg; ... Dorfller-Melly, Janine 2009
add to browser selection
Symptoms and clinical relevance: A dilemma for clinical trials on prevention of venous thromboembolism Bounameaux, Henri; Agnelli, Giancarlo 2013
add to browser selection
The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin Fontana, Pierre; Alberts, P; Sakariassen, K S; Bounameaux, Henri; ... Santana Sorensen, A 2011
add to browser selection
The novel anticoagulants: entering a new era Bounameaux, Henri 2009
add to browser selection
The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism Mavrakanas, Thomas; Bounameaux, Henri 2011
add to browser selection
The pulmonary embolism rule-out criteria (PERC) rule does not safely exclude pulmonary embolism Hugli, O; Righini, Marc Philip; Le Gal, G; Roy, P-M; ... Aujesky, D 2011
add to browser selection
The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodology Méan, Marie; Righini, Marc Philip; Jaeger, Kurt; Beer, Hans-Jürg; ... Aujesky, Drahomir 2013
add to browser selection
Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study Fiessinger, J. N.; Bounameaux, Henri; Cairols, M. A.; Clement, D. L.; ... Turpie, A G. G. 2010
add to browser selection
Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies Di Nisio, Marcello; Vedovati, Maria C; Riera-Mestre, Antoni; Prins, Martin H; ... Lensing, Anthonie W A 2016
add to browser selection
Treatment strategies for acute pulmonary embolism Blondon, Marc; Bounameaux, Henri; Righini, Marc Philip 2009
add to browser selection
Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE study Weitz, J I; Bauersachs, R; Beyer-Westendorf, J; Bounameaux, Henri; ... Prandoni, P 2015
add to browser selection
Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper Abraham, Paul Samuel; Arroyo, Diego A; Giraud, Raphaël; Bounameaux, Henri; Bendjelid, Karim 2018
add to browser selection
Validation of a risk score identifying patients with acute pulmonary embolism, who are at low risk of clinical adverse outcome Nendaz, Mathieu; Bandelier, Patrick Jérôme; Aujesky, Drahomir; Cornuz, Jacques; ... Perrier, Arnaud 2004
add to browser selection
Venous thromboembolism diagnosis: unresolved issues Righini, Marc Philip; Le Gal, G; Bounameaux, Henri 2015
add to browser selection
Venous thromboembolism: contemporary diagnostic and therapeutic aspects Bounameaux, Henri; Righini, Marc Philip; Perrier, Arnaud 2008
add to browser selection
Venous thromboembolism: why does ethnicity matter? Bounameaux, Henri; Rosendaal, Frits R 2011
add to browser selection
Vorapaxar in Patients with Peripheral Artery Disease: Results from TRA2{degrees}P-TIMI 50 Bonaca, Marc P; Scirica, Benjamin M; Creager, Mark A; Olin, Jeffrey W; ... Morrow, David A 2013
add to browser selection
Women, thrombosis, and cancer: A gender-specific analysis Farge, Dominique; Bounameaux, Henri; Bauersachs, Rupert M; Brenner, Benjamin 2017
| 1 | 2 | 3 | next >>